Zobrazeno 1 - 10
of 80
pro vyhledávání: '"Rakhe S"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Pittman DD; Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States., Carrieri C; Pfizer Inc., New York, New York, United States., Soares H; Pfizer Inc., New York, New York, United States., McKay J; Pfizer Inc., Groton, Connecticut, United States., Tan CY; Pfizer Inc., Groton, Connecticut, United States., Liang JZ; Pfizer Inc., New York, New York, United States., Rakhe S; Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States., Marshall JC; Pfizer Inc., Groton, Connecticut, United States., Murphy JE; Rare Disease Research Unit, Pfizer Inc., Cambridge, Massachusetts, United States., Gaitonde P; Pfizer Inc., Cambridge, Massachusetts, United States., Rupon J; Pfizer Inc., Collegeville, Pennsylvania, United States.
Publikováno v:
Thrombosis and haemostasis [Thromb Haemost] 2024 Oct; Vol. 124 (10), pp. 912-921. Date of Electronic Publication: 2024 Jun 11.
Publikováno v:
Russian Journal of Organic Chemistry; Apr2024, Vol. 60 Issue 4, p723-727, 5p
Autor:
Pittman DD; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA., Rakhe S; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA., Bowley SR; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA., Jasuja R; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA., Barakat A; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA., Murphy JE; Rare Disease Research Unit Pfizer Inc. Cambridge Massachusetts USA.
Publikováno v:
Research and practice in thrombosis and haemostasis [Res Pract Thromb Haemost] 2022 Mar 16; Vol. 6 (2), pp. e12679. Date of Electronic Publication: 2022 Mar 16 (Print Publication: 2022).
Autor:
Patel-Hett S; Rare Disease Research Unit, Early Clinical Development, Pfizer Inc, Cambridge, MA, USA., Martin EJ; Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU), Richmond, VA, USA., Mohammed BM; Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU), Richmond, VA, USA.; Department of Clinical Pharmacy, Faculty of Pharmacy, Cairo University, Cairo, Egypt.; Department of Pathology, Microbiology, and Immunology, Vanderbilt University Medical Center, Nashville, TN, USA., Rakhe S; Rare Disease Research Unit, Early Clinical Development, Pfizer Inc, Cambridge, MA, USA., Sun P; Rare Disease Research Unit, Early Clinical Development, Pfizer Inc, Cambridge, MA, USA., Barrett JC; Division of Hematology/Oncology, Department of Internal Medicine, VCU, Richmond, VA, USA., Nolte ME; Division of Hematology/Oncology, Department of Internal Medicine, VCU, Richmond, VA, USA., Kuhn J; Division of Hematology/Oncology, Department of Internal Medicine, VCU, Richmond, VA, USA., Pittman DD; Rare Disease Research Unit, Early Clinical Development, Pfizer Inc, Cambridge, MA, USA., Murphy JE; Rare Disease Research Unit, Early Clinical Development, Pfizer Inc, Cambridge, MA, USA., Brophy DF; Coagulation Advancement Laboratory, Department of Pharmacotherapy & Outcomes Science, Virginia Commonwealth University (VCU), Richmond, VA, USA.
Publikováno v:
Haemophilia : the official journal of the World Federation of Hemophilia [Haemophilia] 2019 Sep; Vol. 25 (5), pp. 797-806. Date of Electronic Publication: 2019 Jul 23.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Parng C; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139. Electronic address: chuenlei.parng@pfizer.com., Singh P; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139., Pittman DD; Pfizer Rare Disease Research Unit, Hematology, Cambridge, Massachusetts 02139., Wright K; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139., Leary B; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139., Patel-Hett S; Pfizer Rare Disease Research Unit, Hematology, Cambridge, Massachusetts 02139., Rakhe S; Pfizer Rare Disease Research Unit, Hematology, Cambridge, Massachusetts 02139., Stejskal J; Pfizer Drug Safety Research and Development, Cambridge, Massachusetts 02139., Peraza M; Pfizer Drug Safety Research and Development, Cambridge, Massachusetts 02139., Dufield D; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139., Murphy JE; Pfizer Rare Disease Research Unit, Hematology, Cambridge, Massachusetts 02139., Webster R; Pfizer Biomedicine Design, Cambridge, Massachusetts 02139.
Publikováno v:
Journal of pharmaceutical sciences [J Pharm Sci] 2018 Jul; Vol. 107 (7), pp. 1995-2004. Date of Electronic Publication: 2018 Mar 20.
Autor:
Wilczyński, Bartosz1,2 (AUTHOR) bartosz.wilczynski@gumed.edu.pl, Juszczyk, Dawid2 (AUTHOR), Zorena, Katarzyna1 (AUTHOR), Mital, Andrzej3 (AUTHOR)
Publikováno v:
Physiotherapy Theory & Practice. Nov2023, Vol. 39 Issue 11, p2470-2478. 9p.
Autor:
Su, Xiaojie1 (AUTHOR) 17111010016@fudan.edu.cn, Huang, Ziqi1 (AUTHOR), Xu, Wei1 (AUTHOR), Wang, Qian1 (AUTHOR), Xing, Lixiao1 (AUTHOR), Lu, Lu1 (AUTHOR), Jiang, Shibo1 (AUTHOR) shibojiang@fudan.edu.cn, Xia, Shuai1 (AUTHOR) shibojiang@fudan.edu.cn
Publikováno v:
Biomolecules (2218-273X). Sep2023, Vol. 13 Issue 9, p1283. 27p.
Autor:
Vallee S; Biogen Idec Hemophilia, Waltham, Massachusetts 02451, USA. sebastien.vallee@biogenidec.com, Rakhe S, Reidy T, Walker S, Lu Q, Sakorafas P, Low S, Bitonti A
Publikováno v:
Journal of interferon & cytokine research : the official journal of the International Society for Interferon and Cytokine Research [J Interferon Cytokine Res] 2012 Apr; Vol. 32 (4), pp. 178-84. Date of Electronic Publication: 2011 Dec 22.